发明名称 |
VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS |
摘要 |
The invention relates to nasally-administered vaccine compositions effective against infection in immuno-compromised populations. One aspect of the invention is directed to the pediatric use of the vaccine of the invention including a vaccine effective in children against seasonal influenza virus strains. A further aspect of the invention is directed to subjects of all age groups when the composition is for pandemic use. |
申请公布号 |
US2015306204(A1) |
申请公布日期 |
2015.10.29 |
申请号 |
US201314650807 |
申请日期 |
2013.12.17 |
申请人 |
EUROCINE VACCINES AB |
发明人 |
Arwidsson Hans;Maltais Anna-Karin |
分类号 |
A61K39/145;A61K39/39;C12N7/00 |
主分类号 |
A61K39/145 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of immunizing an immune-compromised subject against influenza for reducing virus shedding comprising:
administering intranasally to an immuno-compromised subject a composition comprising:
i) one or more non-live influenza virus antigen(s) selected from the group consisting of whole inactivated virus, split virus, subunit influenza antigen, and recombinant antigens, andii) an adjuvant comprising:
one or more carboxylic acids,an aqueous medium, andone or more mono-glycerides. |
地址 |
Solna SE |